Surrozen (SRZN) closed at $32.64 on November 10, 2026, up 2.0% from the previous close, on volume of 190,329 shares (30-day average 485,034).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 12, 2026 | Call Spread | 16-Oct-2630 : 50 C | 4,000 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
H.C. Wainwright Keeps Their Buy Rating on Surrozen (SRZN)
TipRanks (Tue, 10-Nov 6:37 AM ET)
Surrozen GAAP EPS of -$11.02 misses by $9.92
Seeking Alpha News (Tue, 10-Nov 5:09 AM ET)
Surrozen Reports Third Quarter 2026 Financial Results and Provides Business Update
Globe Newswire (Mon, 9-Nov 4:05 PM ET)
Surrozen to Present at Upcoming Healthcare Investor Conference
Globe Newswire (Fri, 6-Nov 4:40 PM ET)
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
Globe Newswire (Tue, 20-Oct 4:59 PM ET)
Globe Newswire (Fri, 2-Oct 8:00 AM ET)
Globe Newswire (Tue, 8-Sep 8:30 AM ET)
Surrozen to Present at Upcoming Healthcare Investor Conferences
Globe Newswire (Wed, 2-Sep 4:05 PM ET)
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Surrozen trades on the NASDAQ stock market under the symbol SRZN.
As of November 10, 2026, SRZN stock price climbed to $32.64 with 190,329 million shares trading.
SRZN has a beta of 1.71, meaning it tends to be more sensitive to market movements. SRZN has a correlation of 0.05 to the broad based SPY ETF.
SRZN has a market cap of $383.64 million. This is considered a Small Cap stock.
Last quarter Surrozen reported $0 in Revenue and -$11.02 earnings per share. This fell short of revenue expectation by $-380,000 and missed earnings estimates by -$9.70.
In the last 3 years, SRZN traded as high as $37.83 and as low as $5.10.
The top ETF exchange traded funds that SRZN belongs to (by Net Assets): VTI, IWM, JSMD, VXF, IWO.
SRZN has outperformed the market in the last year with a price return of +167.5% while the SPY ETF gained +12.9%. SRZN has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +27.4% and +19.6%, respectively, while the SPY returned -2.8% and -2.0%, respectively.
SRZN support price is $30.05 and resistance is $33.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SRZN shares will trade within this expected range on the day.
